Get updates delivered to you daily. Free and customizable.
targetedonc.com
Phase 1/2 Trial of Silmitasertib in Sarcoma and Brain Tumors to Proceed
By Sabrina Serani,
1 day agoBy Sabrina Serani,
1 day agoRead in NewsBreak
Comments / 0
Add a Comment
YOU MAY ALSO LIKE
Reuters3 days ago
Cancer Health1 day ago
onclive.com1 day ago
Servier snags FDA approval for Voranigo, the first targeted therapy for a common type of brain tumor
FiercePharma3 days ago
Savannah, GA24 days ago
Ocilla, GA23 days ago
Florida State10 days ago
healio.com18 days ago
Chicago, IL25 days ago
Orange County, FL9 days ago
The Dogington Post13 hours ago
ascopost.com20 hours ago
Tennessee State16 days ago
Explore Beaufort SC16 days ago
Appling County, GA3 days ago
ajmc.com13 days ago
Get updates delivered to you daily. Free and customizable.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.
Comments / 0